Longdom Conferences extends our immense pleasure and honor to invite you to attend " 3rd World Conference on No diabetes and Obestity" on Jun 22-23, 2022 in New York, USA. World No Diabetes Conference is mainly focuses on the theme “ Breakthroughs in Diabetes treatments and expose the latest developments” Guided by a line-up of expert speakers, the agenda will address some of the major issues related to Diabetes and its related subjects to establish a connection for exchanging ideas. Our conference agenda is to present keynote talks, plenary sessions, discussion panels, Poster Presentations, symposia, young researcher’s forum, video Presentations, and Workshops.

World No Diabetes Conference is comprised of various tracks and sessions designed to offer comprehensive sessions that address current issues in the field of Advanced Technologies Treatments for Diabetes.

Sessions: 1 Diabetic Retinopathy

Diabetes damages the blood vessels in the retina. Diabetic retinopathy happens when these small blood vessels spill blood and other liquids. This causes swelling of retinal tissue which results in cloudy or obscured vision. The condition usually affects both the eyes. The longer the person with diabetes the more likely he will develop diabetic retinopathy. When left untreated, diabetic retinopathy can cause blindness. Diabetic retinopathy is perceived in the midst of an eye examination that consolidates visual keenness test, Fundus Fluorescence angiography(FFA), and Optical soundness tomography (OCT). The NEI is coordinating and supporting the investigations on the new approaches to identify, treat, and deflect vision incident in people with diabetes.

Diabetes is a great danger factor for cardiovascular disease (CVD). Vascular issues fuse retinopathy and nephropathy, fringe vascular contamination (PVD), stroke, and coronary conduit disease (CAD). Diabetes furthermore impacts the heart muscle, causing both systolic and diastolic cardiovascular breakdowns. The etiology of this abundance cardiovascular dreariness and mortality isn't totally known. Confirmations show that hyperglycemia, the indication of diabetes, adds to myocardial harm after ischemic occasions. It is unmistakably by all account not the only aim, in light of the fact that both pre-diabetes and the presence of the metabolic disorder, even in norm glycemic patients, increment the danger of most sorts of cardio vascular sicknesses.

Sessions: 3 Diabetes and Endocrinology

Endocrinology is a part of physiology and medication worried about endocrine organs and chemicals. The specialists who are expert in managing endocrine organ problems and capacities are called as Endocrinologists. Diabetes is a persistent illness which happens when the beta cells of pancreas neglect to deliver insulin, or when the body can't utilize the insulin it produces.

Sessions: 4 Diabetes and Skin Complications

Skin Complications in diabetes incorporate Bacterial and parasitic contaminations, Acanthuses nigricans, Diabetic dermopathy, Necrobiosis lipoidica diabeticorum, Diabetic rankles, Eruptive xanthomatosis, Digital sclerosis, Disseminated granuloma annulare. Appropriate cleanliness and care in expected to forestall diseases and different difficulties.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 5 Insulin Medication

Insulin clinical consideration is typically suggested for patients with kind a couple of diabetes partner degreed an underlying A1C level greater than 9 %, or if diabetes is uncontrolled notwithstanding ideal oral glycemic clinical consideration. Inward emission clinical consideration is likewise started as growth, starting at 0.3 units per weight unit, or as substitution, starting at 0.6 to 1.0 units per weight unit. Aldohexose the board, unfriendly impacts, cost, adherence, and personal satisfaction must be constrained to be considered once choosing clinical consideration. Hostile to diabetic medication should be proceeded if potential because of its confirmed to downsize all-cause mortality and vessel occasions in overweight patients with diabetes infections.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 6 Advanced Technologies for the Treatment of Diabetes

The concept of 'new technologies' for type 1 diabetes and new discovery and advanced type 2 diabetes treatment has expanded in recent years at a rate that some might consider comparable to 'Moore’s Law', and the sheer number of new technologies entering into the type 1 diabetes marketplace is also growing at a remarkable rate. From the patient’s perspective, this is not only exciting but can lead to a sense of optimism. Technologies that today are growing commonplace (e.g. insulin pumps, rapid HbA1c monitoring, etc come under new therapeutic mechanisms of diabetes. Indeed, it could be argued that the major advances in type 1 diabetes care made within the last quarter of a century have come from technology rather than biology. At the same time, not all new technologies succeed (e.g. the Glucowatch), regardless of their purported promise. Both type 1 diabetes patients and their healthcare providers will soon see a series of further advanced medical technologies used in hospital and new technologies and novel therapies in diabetes treatment whose basis is tied to the notion of improving the lives of those with the disease.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 7 Diabetes Nursing

One of the most significant features of diabetes management is the self-management of diabetes which can be effectively achieved, and complications prevented with the help and support of the nursing team. Diabetes specialist nurses play an essential role in screening diabetic persons, detecting early onset of diabetes, considering nutritional needs of the patient, promoting self-management, providing prevention advice, spreading awareness on diabetes and providing health education. It is very necessary for nurses to be well educated, trained and skilled sufficiently to be able to proficiently deliver care, support self-management and provide advice to diabetic persons.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 8 Diabetes Research in Clinical Practice

Novel therapeutic targets available for diabetes includes Incretin based therapies, oral therapeutic agents like secretagogues, beta cell regeneration & proliferation and stem cell therapies. Embryonic stem cell and fetal precursor cell transplantation therapies are the major stem cell therapies available for Diabetes. Apart from the above, various computational approaches in Diabetes management control have been introduced recently which are playing an important role in identification of genes causing diabetes helping in Early Detection of Diabetes. These processes are also useful in studying the chemical etiologies of Diabetes uncovering various treatment prospects and model construction processes for survival prediction.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 9 Transplantation of Diabetes

Getting a new heart, liver, kidney, lung, or other organ can save your life. Sometimes, it can also lead to type 2 diabetes. Many people can stop taking steroids after 6 months or so. This may solve the problem. If scientists can develop safe immunosuppressant’s that always work, then many people with type 1 diabetes may choose to have pancreas transplants. Until then, many doctors think islet transplants are a better option even after performing clinical trials on islet transplants. Islets are clusters of cells in the pancreas that make insulin. In people with type 1 diabetes, islet cells are destroyed. Only 1-2% of the pancreas is made up of islet cells. In pancreatic islet transplantation, cells are taken from a donor pancreas and transferred into another person. Once implanted, the new islets begin to make and release insulin. Researchers hope that islet transplantation will help people with type 1 diabetes live without daily injections of insulin.

Keywords:Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Sessions: 10 Emerging Focus in Diabetes Research

Diabetes is a common chronic disease that imposes considerable demands on the individual healthcare system. People with diabetes have a higher rate of cardiovascular disease than those without diabetes and are at increased risk for kidney failure, lower limb amputation and blindness. Obesity is a significant risk factor for diabetes and the prevalence of obesity in children and adults has dramatically increased in the past four decades. Diabetic dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.

Keywords: Diabetes Conferences | Conferences on Diabetes | Meetings on Diabetes | Endocrinology Conferences | Diabetes Mellitus | Pancreas | Congress on Diabetes | Euro Diabetes Conferences | Retinopathy | Obesity

Market Analysis

Global endocrinology drugs market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of endocrine diseases. These diseases include endocrine gland associated disorders such as Addison’s disease, gigantism, goiter, Cushing’s syndrome, polycystic ovary syndrome (PCOS), diabetes, hypertension, hyperlipidemia, acromegaly, thyroiditis, and osteomalacia. Rising adolescent population base which is more prone to such diseases due to hormonal imbalances also tends to drive the growth of endocrinology drugs market. Unhealthy lifestyle characteristics such as high intake of cholesterol, work stress and weight gain which ultimately leading to malfunctioning of the endocrine system, inception of new drug delivery systems, extensive research and development, and the rise in disposable income propels the growth of endocrinology drugs market. Rapid uptake of novel dosage forms and formulations of existing drugs is expected to increase number of patients for treatment of endocrine disorders thus leading to market growth.

Major Associations of Endocrinology around the Globe

Endocrine Society
American Association of Clinical Endocrinologists
The American Association of Endocrine Surgeons
Association of Program Directors in Endocrinology, Diabetes and Metabolism
Society for Endocrinology
Brazilian Society of Surgical Endocrinology
British Society for Paediatric Endocrinology and Diabetes
European Society of Endocrinology
International Society of Endocrinology

Past Conference Reports

World NO Diabetes 2020

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making World NO Diabetes 2020 Webinar the best ever!
"Webinar on World NO Diabetes", hosted by the Longdom Conference was held during July 11, 2020 at London, UK. Based on the theme “Commitment to Excellence in the Field of Diabetes and Obesity"